Juliet Silberstein1, Philip D Harvey1,2. 1. a University of Miami Miller School of Medicine , Miami , FL , USA. 2. b Research Service, Bruce W. Cater VA Medical Center , Miami VA Healthcare System , Miami , FL , USA.
Abstract
INTRODUCTION: Individuals with schizophrenia present across a spectrum of symptomatology. Disability remains a debilitating reality across varying disease presentations and remains pervasive despite psychiatric medications. Cognition (neuro/social cognition) and negative symptoms have emerged as the strongest predictors of real-world disability, but account for <50% of the variance in outcomes. METHODS: Our attempts to determine what accounts for the remaining 50% of variance has shown that poor introspective accuracy (IA) may be the most potent predictor of functional outcomes 25% of individuals with schizophrenia. We define IA as the adequacy of self-assessments of ability, skills, performance, or decisions. We suggest that IA is a progression of metacognition and can extend beyond cognition to include misestimation of prior and likely future performance in social or other adaptively relevant situations. RESULTS: Additionally, IA is bidirectional and self-orientated. Emerging research has found that IA of neurocognitive ability better predicts everyday functional deficits than scores on performance-based measures or neurocognitive skills and has found that IA of social cognition accounts unique variance in real-world disability above social cognitive performance. DISCUSSION: We argue that impaired IA, affecting 25-50% of patients with schizophrenia, in the absence or minimal presence of other impairments might be the most powerful predictor of functional outcomes.
INTRODUCTION: Individuals with schizophrenia present across a spectrum of symptomatology. Disability remains a debilitating reality across varying disease presentations and remains pervasive despite psychiatric medications. Cognition (neuro/social cognition) and negative symptoms have emerged as the strongest predictors of real-world disability, but account for <50% of the variance in outcomes. METHODS: Our attempts to determine what accounts for the remaining 50% of variance has shown that poor introspective accuracy (IA) may be the most potent predictor of functional outcomes 25% of individuals with schizophrenia. We define IA as the adequacy of self-assessments of ability, skills, performance, or decisions. We suggest that IA is a progression of metacognition and can extend beyond cognition to include misestimation of prior and likely future performance in social or other adaptively relevant situations. RESULTS: Additionally, IA is bidirectional and self-orientated. Emerging research has found that IA of neurocognitive ability better predicts everyday functional deficits than scores on performance-based measures or neurocognitive skills and has found that IA of social cognition accounts unique variance in real-world disability above social cognitive performance. DISCUSSION: We argue that impaired IA, affecting 25-50% of patients with schizophrenia, in the absence or minimal presence of other impairments might be the most powerful predictor of functional outcomes.
Entities:
Keywords:
Schizophrenia; metacognition; neurocognition; social cognition
Authors: Christopher R Bowie; Elizabeth W Twamley; Hannah Anderson; Brooke Halpern; Thomas L Patterson; Philip D Harvey Journal: J Psychiatr Res Date: 2006-10-02 Impact factor: 4.791
Authors: Samir Sabbag; Elizabeth M Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson; Philip D Harvey Journal: Schizophr Res Date: 2011-05-26 Impact factor: 4.939
Authors: Christopher R Bowie; Abraham Reichenberg; Thomas L Patterson; Robert K Heaton; Philip D Harvey Journal: Am J Psychiatry Date: 2006-03 Impact factor: 18.112
Authors: Dante Durand; Martin Strassnig; Samir Sabbag; Felicia Gould; Elizabeth W Twamley; Thomas L Patterson; Philip D Harvey Journal: Eur Neuropsychopharmacol Date: 2014-07-25 Impact factor: 4.600
Authors: Philip D Harvey; Elizabeth Deckler; Mackenzie T Jones; L Fredrik Jarskog; David L Penn; Amy E Pinkham Journal: J Psychiatr Res Date: 2019-05-10 Impact factor: 4.791
Authors: Ellaheh Gohari; Raeanne C Moore; Colin A Depp; Robert A Ackerman; Amy E Pinkham; Philip D Harvey Journal: Psychiatry Res Date: 2022-02-25 Impact factor: 11.225
Authors: Dante Durand; Martin T Strassnig; Raeanne C Moore; Colin A Depp; Robert A Ackerman; Amy E Pinkham; Philip D Harvey Journal: Schizophr Res Date: 2021-03-02 Impact factor: 4.939
Authors: Colin A Depp; Snigdha Kamarsu; Tess F Filip; Emma M Parrish; Philip D Harvey; Eric L Granholm; Samantha Chalker; Raeanne C Moore; Amy Pinkham Journal: Psychol Med Date: 2021-01-12 Impact factor: 10.592
Authors: Bianca A Tercero; Michelle M Perez; Noreen Mohsin; Raeanne C Moore; Colin A Depp; Robert A Ackerman; Amy E Pinkham; Philip D Harvey Journal: J Psychiatr Res Date: 2021-06-11 Impact factor: 5.250